CD79A and COVID-19: Overall, similar RBD-specific IgG, IgM, or IgA, N-specific IgG titers (Figure 2A), and neutralizing activity (Figure 2B and Supplemental Figure 1B) between pregnant and nonpregnant women with acute or convalescent COVID-19 were observed.